Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
133 hedge funds and large institutions have $758M invested in Amedisys in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 15 closing their positions.
206% more call options, than puts
Call options by funds: $5.88M | Put options by funds: $1.92M
2% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 48
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 137 → 133 (-4)
10% less capital invested
Capital invested by funds: $843M → $758M (-$84.1M)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Top Buyers
Top Sellers
AMED Hedge Fund Activity: Q1 2015 in Review
133 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2015, worth a combined $758M — down 10% from $843M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AMED and 13 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 49 added.
The largest buyer was Millennium Management, adding an estimated $13M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $8.91M sold.
- 133 institutional investors held Amedisys (AMED) as of Q1 2015, down from 137 in Q4 2014.
- Funds reported $758M of Amedisys stock for Q1 2015, down 10% quarter-over-quarter.
- 13 funds opened new Amedisys positions in Q1 2015 and 15 closed out, a net change of -2 holders.
- The largest Amedisys buyer in Q1 2015 was Millennium Management, an estimated $13M added.
- The largest Amedisys seller in Q1 2015 was Fuller & Thaler Asset Management, an estimated $8.91M sold.
Based on aggregated 13F filings for Q1 2015.